| Original language | English |
|---|---|
| Pages (from-to) | 1209-1217 |
| Number of pages | 9 |
| Journal | Haematologica |
| Volume | 103 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2018 |
Keywords
- bendamustine
- chlorambucil
- fludarabine
- ibrutinib
- rituximab, adult
- aged
- anemia
- Article
- autoimmune hemolytic anemia
- cancer chemotherapy
- cancer staging
- chronic lymphatic leukemia
- comorbidity
- creatinine clearance
- cytopenia
- drug efficacy
- drug safety
- encephalitis
- febrile neutropenia
- female
- human
- lung infection
- major clinical study
- male
- neutropenia
- observational study
- overall survival
- progression free survival
- rash
- salvage therapy
- thrombocytopenia
- very elderly
Cite this
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study. / Cuneo, A.; Follows, G.; Rigolin, G.M.; Piciocchi, A.; Tedeschi, A.; Trentin, L.; Perez, A.M.; Coscia, M.; Laurenti, L.; Musuraca, G.; Farina, L.; Delgado, A.R.; Orlandi, E.M.; Galieni, P.; Mauro, F.R.; Visco, C.; Amendola, A.; Billio, A.; Marasca, R.; Chiarenza, A.; Meneghini, V.; Ilariucci, F.; Marchetti, M.; Molica, S.; Re, F.; Gaidano, G.; Gonzalez, M.; Forconi, F.; Ciolli, S.; Cortelezzi, A.; Montillo, M.; Smolej, L.; Schuh, A.; Eyre, T.A.; Kennedy, B.; Bowles, K.M.; Vignetti, M.; De La Serna, J.; Moreno, C.; Foà, R.; Ghia, P.; Party, GIMEMA; (ERIC), European Research Initiative on CLL; forum, UK CLL.
In: Haematologica, Vol. 103, No. 7, 2018, p. 1209-1217.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study
AU - Cuneo, A.
AU - Follows, G.
AU - Rigolin, G.M.
AU - Piciocchi, A.
AU - Tedeschi, A.
AU - Trentin, L.
AU - Perez, A.M.
AU - Coscia, M.
AU - Laurenti, L.
AU - Musuraca, G.
AU - Farina, L.
AU - Delgado, A.R.
AU - Orlandi, E.M.
AU - Galieni, P.
AU - Mauro, F.R.
AU - Visco, C.
AU - Amendola, A.
AU - Billio, A.
AU - Marasca, R.
AU - Chiarenza, A.
AU - Meneghini, V.
AU - Ilariucci, F.
AU - Marchetti, M.
AU - Molica, S.
AU - Re, F.
AU - Gaidano, G.
AU - Gonzalez, M.
AU - Forconi, F.
AU - Ciolli, S.
AU - Cortelezzi, A.
AU - Montillo, M.
AU - Smolej, L.
AU - Schuh, A.
AU - Eyre, T.A.
AU - Kennedy, B.
AU - Bowles, K.M.
AU - Vignetti, M.
AU - De La Serna, J.
AU - Moreno, C.
AU - Foà, R.
AU - Ghia, P.
AU - Party, GIMEMA
AU - (ERIC), European Research Initiative on CLL
AU - forum, UK CLL
PY - 2018
Y1 - 2018
KW - bendamustine
KW - chlorambucil
KW - fludarabine
KW - ibrutinib
KW - rituximab, adult
KW - aged
KW - anemia
KW - Article
KW - autoimmune hemolytic anemia
KW - cancer chemotherapy
KW - cancer staging
KW - chronic lymphatic leukemia
KW - comorbidity
KW - creatinine clearance
KW - cytopenia
KW - drug efficacy
KW - drug safety
KW - encephalitis
KW - febrile neutropenia
KW - female
KW - human
KW - lung infection
KW - major clinical study
KW - male
KW - neutropenia
KW - observational study
KW - overall survival
KW - progression free survival
KW - rash
KW - salvage therapy
KW - thrombocytopenia
KW - very elderly
U2 - 10.3324/haematol.2018.189837
DO - 10.3324/haematol.2018.189837
M3 - Article
VL - 103
SP - 1209
EP - 1217
JO - Haematologica
JF - Haematologica
SN - 0390-6078
IS - 7
ER -